Compounds

Compounds

Search transparent compound records with identity, proposed mechanisms, evidence maps, safety context, COA limits, and supplier-document questions.

Melanocortin medicine Evidence 5/5

Bremelanotide

Bremelanotide is tracked as part of the peptide, metabolic, mitochondrial, NAD, or longevity research landscape, with claims separated by evidence type and product documentation.

Evidence map
GLP-1 medicine Evidence 5/5

Semaglutide

A GLP-1 receptor agonist with controlled clinical evidence for specific approved uses, where product status, jurisdiction, and formulation matter.

Evidence map
GHRH analog medicine Evidence 5/5

Tesamorelin

Tesamorelin is tracked as part of the peptide, metabolic, mitochondrial, NAD, or longevity research landscape, with claims separated by evidence type and product documentation.

Evidence map
GIP/GLP-1 medicine Evidence 5/5

Tirzepatide

A dual GIP/GLP-1 receptor agonist with strong clinical evidence in approved-product contexts and separate questions for compounded products.

Evidence map
Energy metabolism compound Evidence 4/5

Creatine

Creatine is tracked as part of the peptide, metabolic, mitochondrial, NAD, or longevity research landscape, with claims separated by evidence type and product documentation.

Evidence map
Mitochondrial peptide Evidence 4/5

Elamipretide

Elamipretide is tracked as part of the peptide, metabolic, mitochondrial, NAD, or longevity research landscape, with claims separated by evidence type and product documentation.

Evidence map
Metabolic medicine Evidence 4/5

Metformin

Metformin is tracked as part of the peptide, metabolic, mitochondrial, NAD, or longevity research landscape, with claims separated by evidence type and product documentation.

Evidence map
NAD+ precursor Evidence 4/5

Nicotinamide riboside

Nicotinamide riboside is tracked because it appears in peptide, NAD, metabolic, or longevity discussions and needs claim-by-claim evidence review.

Evidence map
NAD+ precursor Evidence 4/5

NMN

A NAD+ precursor studied in metabolism and aging-biology contexts, with stronger human relevance than many research peptides but still outcome-specific evidence.

Evidence map
mTOR inhibitor medicine Evidence 4/5

Rapamycin

Rapamycin is tracked as part of the peptide, metabolic, mitochondrial, NAD, or longevity research landscape, with claims separated by evidence type and product documentation.

Evidence map
Triple incretin agonist Evidence 4/5

Retatrutide

An investigational triple GLP-1/GIP/glucagon receptor agonist with strong phase 2 signals but no approved-product status yet.

Evidence map
Alpha-glucosidase inhibitor Evidence 3/5

Acarbose

Acarbose is tracked as part of the peptide, metabolic, mitochondrial, NAD, or longevity research landscape, with claims separated by evidence type and product documentation.

Evidence map
Plant alkaloid Evidence 3/5

Berberine

Berberine is tracked as part of the peptide, metabolic, mitochondrial, NAD, or longevity research landscape, with claims separated by evidence type and product documentation.

Evidence map
Copper peptide Evidence 3/5

GHK-Cu

A copper-binding tripeptide often discussed in skin, wound-context, and cosmetic research, with evidence varying sharply by formulation and outcome.

Evidence map
Amino acid Evidence 3/5

Glycine

Glycine is tracked as part of the peptide, metabolic, mitochondrial, NAD, or longevity research landscape, with claims separated by evidence type and product documentation.

Evidence map
Polyphenol compound Evidence 3/5

Quercetin

Quercetin is tracked as part of the peptide, metabolic, mitochondrial, NAD, or longevity research landscape, with claims separated by evidence type and product documentation.

Evidence map
Polyphenol compound Evidence 3/5

Resveratrol

Resveratrol is tracked as part of the peptide, metabolic, mitochondrial, NAD, or longevity research landscape, with claims separated by evidence type and product documentation.

Evidence map
GHRH peptide Evidence 3/5

Sermorelin

Sermorelin is tracked as part of the peptide, metabolic, mitochondrial, NAD, or longevity research landscape, with claims separated by evidence type and product documentation.

Evidence map
Polyamine compound Evidence 3/5

Spermidine

Spermidine is tracked as part of the peptide, metabolic, mitochondrial, NAD, or longevity research landscape, with claims separated by evidence type and product documentation.

Evidence map
Amino sulfonic acid Evidence 3/5

Taurine

Taurine is tracked as part of the peptide, metabolic, mitochondrial, NAD, or longevity research landscape, with claims separated by evidence type and product documentation.

Evidence map
Immune peptide Evidence 3/5

Thymosin alpha-1

Thymosin alpha-1 is tracked as part of the peptide, metabolic, mitochondrial, NAD, or longevity research landscape, with claims separated by evidence type and product documentation.

Evidence map
Mitophagy compound Evidence 3/5

Urolithin A

Urolithin A is tracked as part of the peptide, metabolic, mitochondrial, NAD, or longevity research landscape, with claims separated by evidence type and product documentation.

Evidence map
TCA-cycle metabolite Evidence 2/5

Alpha-ketoglutarate

Alpha-ketoglutarate is tracked as part of the peptide, metabolic, mitochondrial, NAD, or longevity research landscape, with claims separated by evidence type and product documentation.

Evidence map
Peptide Evidence 2/5

BPC-157

A synthetic peptide discussed for tissue repair and gastrointestinal models, with most public claims still relying on preclinical research.

Evidence map
GHRH analog peptide Evidence 2/5

CJC-1295

CJC-1295 is tracked as part of the peptide, metabolic, mitochondrial, NAD, or longevity research landscape, with claims separated by evidence type and product documentation.

Evidence map
Longevity peptide Evidence 2/5

Epitalon

Epitalon is tracked because it appears in peptide, NAD, metabolic, or longevity discussions and needs claim-by-claim evidence review.

Evidence map
Flavonoid senolytic candidate Evidence 2/5

Fisetin

Fisetin is tracked as part of the peptide, metabolic, mitochondrial, NAD, or longevity research landscape, with claims separated by evidence type and product documentation.

Evidence map
Mitochondrial peptide Evidence 2/5

Humanin

Humanin is tracked as part of the peptide, metabolic, mitochondrial, NAD, or longevity research landscape, with claims separated by evidence type and product documentation.

Evidence map
Ghrelin receptor peptide Evidence 2/5

Ipamorelin

Ipamorelin is tracked as part of the peptide, metabolic, mitochondrial, NAD, or longevity research landscape, with claims separated by evidence type and product documentation.

Evidence map
Anti-inflammatory tripeptide Evidence 2/5

KPV

KPV is tracked because it appears in peptide, NAD, metabolic, or longevity discussions and needs claim-by-claim evidence review.

Evidence map
Antimicrobial peptide Evidence 2/5

LL-37

LL-37 is tracked as part of the peptide, metabolic, mitochondrial, NAD, or longevity research landscape, with claims separated by evidence type and product documentation.

Evidence map
Melanocortin peptide Evidence 2/5

Melanotan II

Melanotan II is tracked because it appears in peptide, NAD, metabolic, or longevity discussions and needs claim-by-claim evidence review.

Evidence map
Mitochondrial peptide Evidence 2/5

MOTS-c

MOTS-c is tracked because it appears in peptide, NAD, metabolic, or longevity discussions and needs claim-by-claim evidence review.

Evidence map
NAD+ coenzyme Evidence 2/5

NAD+

NAD+ is tracked because it appears in peptide, NAD, metabolic, or longevity discussions and needs claim-by-claim evidence review.

Evidence map
Neuropeptide analog Evidence 2/5

Selank

Selank is tracked as part of the peptide, metabolic, mitochondrial, NAD, or longevity research landscape, with claims separated by evidence type and product documentation.

Evidence map
Neuropeptide analog Evidence 2/5

Semax

Semax is tracked because it appears in peptide, NAD, metabolic, or longevity discussions and needs claim-by-claim evidence review.

Evidence map
Peptide Evidence 2/5

TB-500

A peptide commonly associated with thymosin beta-4 discussions and recovery claims, where evidence must be separated by exact molecule and model.

Evidence map
GH fragment peptide Evidence 1/5

AOD-9604

AOD-9604 is tracked as part of the peptide, metabolic, mitochondrial, NAD, or longevity research landscape, with claims separated by evidence type and product documentation.

Evidence map
Telomerase-associated compound Evidence 1/5

Cycloastragenol

Cycloastragenol is tracked as part of the peptide, metabolic, mitochondrial, NAD, or longevity research landscape, with claims separated by evidence type and product documentation.

Evidence map
Sleep peptide Evidence 1/5

DSIP

DSIP is tracked because it appears in peptide, NAD, metabolic, or longevity discussions and needs claim-by-claim evidence review.

Evidence map